Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma

NCT03418909 · Copenhagen University Hospital, Rigshospitalet · Updated 30 March 2023

What is being tested
Primary Trans Oral Robotic Surgery (TORS); Radio(chemo)therapy
For
Oropharynx Cancer; Pain; Swallowing Disorder; Quality of Life; Saliva Altered; Human Papilloma Virus
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 44 people. The full rules are on the registry page.
Where
Denmark
When
Starts or started 1 April 2017, ends 30 June 2024. Registered 1 Feb 2018.
Results
None posted yet.

In the researchers' words

To investigate the treatment related effects of transoral robotic surgery (TORS) or oncological treatment of oropharyngeal squamous cell carcinoma with a 1-year follow up.
ClinicalTrials.gov, NCT03418909

Sites

  • RigshospitaletCopenhagen, Denmark